BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38279366)

  • 1. Familial chilblain lupus with TREX1 mutation and cerebrovascular disease.
    Nohara T; Yanagi T; Yabe I; Ota N; Kanazawa N; Ujiie H; Kosumi H; Mai Y; Shimizu H
    Lancet Rheumatol; 2020 Nov; 2(11):e724. PubMed ID: 38279366
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3' repair exonuclease 1 (TREX1).
    Günther C; Berndt N; Wolf C; Lee-Kirsch MA
    JAMA Dermatol; 2015 Apr; 151(4):426-31. PubMed ID: 25517357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus.
    Lee-Kirsch MA; Chowdhury D; Harvey S; Gong M; Senenko L; Engel K; Pfeiffer C; Hollis T; Gahr M; Perrino FW; Lieberman J; Hubner N
    J Mol Med (Berl); 2007 May; 85(5):531-7. PubMed ID: 17440703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial chilblain lupus due to a novel mutation in TREX1 associated with Aicardi-Goutie'res syndrome.
    Yi C; Li Q; Xiao J
    Pediatr Rheumatol Online J; 2020 Apr; 18(1):32. PubMed ID: 32293470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Clinical Response to Janus Kinase Inhibition in Patients With Familial Chilblain Lupus and TREX1 Mutation.
    Zimmermann N; Wolf C; Schwenke R; Lüth A; Schmidt F; Engel K; Lee-Kirsch MA; Günther C
    JAMA Dermatol; 2019 Mar; 155(3):342-346. PubMed ID: 30673078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial chilblain lupus--a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1.
    Günther C; Meurer M; Stein A; Viehweg A; Lee-Kirsch MA
    Dermatology; 2009; 219(2):162-6. PubMed ID: 19478477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Type I Interferon Primed Dendritic Cell Subpopulation in TREX1 Mutant Chilblain Lupus Patients.
    Eugster A; Müller D; Gompf A; Reinhardt S; Lindner A; Ashton M; Zimmermann N; Beissert S; Bonifacio E; Günther C
    Front Immunol; 2022; 13():897500. PubMed ID: 35911727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A homozygote TREX1 mutation in two siblings with different phenotypes: Chilblains and cerebral vasculitis.
    Kisla Ekinci RM; Balci S; Bisgin A; Altintas DU; Yilmaz M
    Eur J Med Genet; 2017 Dec; 60(12):690-694. PubMed ID: 28919362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease.
    Grieves JL; Fye JM; Harvey S; Grayson JM; Hollis T; Perrino FW
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5117-22. PubMed ID: 25848017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial chilblain lupus due to a gain-of-function mutation in STING.
    König N; Fiehn C; Wolf C; Schuster M; Cura Costa E; Tüngler V; Alvarez HA; Chara O; Engel K; Goldbach-Mansky R; Günther C; Lee-Kirsch MA
    Ann Rheum Dis; 2017 Feb; 76(2):468-472. PubMed ID: 27566796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus.
    Lee-Kirsch MA; Gong M; Chowdhury D; Senenko L; Engel K; Lee YA; de Silva U; Bailey SL; Witte T; Vyse TJ; Kere J; Pfeiffer C; Harvey S; Wong A; Koskenmies S; Hummel O; Rohde K; Schmidt RE; Dominiczak AF; Gahr M; Hollis T; Perrino FW; Lieberman J; Hübner N
    Nat Genet; 2007 Sep; 39(9):1065-7. PubMed ID: 17660818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photosensitivity and cGAS-Dependent IFN-1 Activation in Patients with Lupus and TREX1 Deficiency.
    Berndt N; Wolf C; Fischer K; Cura Costa E; Knuschke P; Zimmermann N; Schmidt F; Merkel M; Chara O; Lee-Kirsch MA; Günther C
    J Invest Dermatol; 2022 Mar; 142(3 Pt A):633-640.e6. PubMed ID: 34400195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: A novel type I interferon primed dendritic cell subpopulation in TREX1 mutant chilblain lupus patients.
    Eugster A; Müller D; Gompf A; Reinhardt S; Lindner A; Ashton M; Zimmermann N; Beissert S; Bonifacio E; Günther C
    Front Immunol; 2022; 13():1094578. PubMed ID: 36518762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupus.
    Yamashiro K; Tanaka R; Li Y; Mikasa M; Hattori N
    J Neurol; 2013 Oct; 260(10):2653-5. PubMed ID: 23989343
    [No Abstract]   [Full Text] [Related]  

  • 15. TREX-1-Related Disease Associated with the Presence of Cryofibrinogenemia.
    Paradis C; Cadieux-Dion M; Meloche C; Gravel M; Paradis J; Des Roches A; Leclerc G; Cossette P; Begin P
    J Clin Immunol; 2019 Jan; 39(1):118-125. PubMed ID: 30685859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome.
    Fye JM; Orebaugh CD; Coffin SR; Hollis T; Perrino FW
    J Biol Chem; 2011 Sep; 286(37):32373-82. PubMed ID: 21808053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutières syndrome.
    Tüngler V; Silver RM; Walkenhorst H; Günther C; Lee-Kirsch MA
    Br J Dermatol; 2012 Jul; 167(1):212-4. PubMed ID: 22356656
    [No Abstract]   [Full Text] [Related]  

  • 18. Human disease phenotypes associated with mutations in TREX1.
    Rice GI; Rodero MP; Crow YJ
    J Clin Immunol; 2015 Apr; 35(3):235-43. PubMed ID: 25731743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical properties of mammalian TREX1 and its association with DNA replication and inherited inflammatory disease.
    Lindahl T; Barnes DE; Yang YG; Robins P
    Biochem Soc Trans; 2009 Jun; 37(Pt 3):535-8. PubMed ID: 19442247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome/familial chilblain lupus.
    Abe J; Izawa K; Nishikomori R; Awaya T; Kawai T; Yasumi T; Hiragi N; Hiragi T; Ohshima Y; Heike T
    Rheumatology (Oxford); 2013 Feb; 52(2):406-8. PubMed ID: 22829693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.